Effectiveness of neuraminidase inhibitors for preventing staff absenteeism during pandemic influenza

被引:14
作者
Lee, Vernon J. [1 ]
Chen, Mark I. [1 ]
机构
[1] Tan Tock Seng Hosp, Singapore, Singapore
关键词
D O I
10.3201/eid1303.060309
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We used a deterministic SEIR (susceptible-exposed-infectious-removed) meta-population model, together with scenario, sensitivity, and simulation analyses, to determine stockpiling strategies for neuraminidase inhibitors that would minimize absenteeism among healthcare workers. A pandemic with a basic reproductive number (R-0) of 2.5 resulted in peak absenteeism of 10%. Treatment decreased peak absenteeism to 8%, while 8 weeks' prophylaxis reduced it to 2%. For pandemics with higher R-0, peak absenteeism exceeded 20% occasionally and 6 weeks' prophylaxis reduced peak absenteeism by 75%. Insufficient duration of prophylaxis increased peak absenteeism compared with treatment only. Earlier pandemic detection and initiation of prophylaxis may render shorter prophylaxis durations ineffective. Eight weeks' prophylaxis substantially reduced peak absenteeism under a broad range of assumptions for severe pandemics (peak absenteeism > 10%). Small investments in treatment and prophylaxis, if adequate and timely, can reduce absenteeism among essential staff.
引用
收藏
页码:449 / 457
页数:9
相关论文
共 21 条
  • [1] Balicer RD, 2005, EMERG INFECT DIS, V11, P1280
  • [2] Chik K. W., 2004, Hong Kong Medical Journal, V10, P103
  • [3] Influenza-associated deaths in tropical Singapore
    Chow, A
    Ma, S
    Ling, AE
    Chew, SK
    [J]. EMERGING INFECTIOUS DISEASES, 2006, 12 (01) : 114 - 121
  • [4] Preparing for pandemic influenza: Should hospitals stockpile oseltamivir?
    Cinti, S
    Chenoweth, C
    Monto, AS
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2005, 26 (11) : 852 - 854
  • [5] Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials
    Cooper, NJ
    Sutton, AJ
    Abrams, KR
    Wailoo, A
    Turner, DA
    Nicholson, KG
    [J]. BRITISH MEDICAL JOURNAL, 2003, 326 (7401): : 1235 - +
  • [6] Influenza
    Cox, NJ
    Subbarao, K
    [J]. LANCET, 1999, 354 (9186) : 1277 - 1282
  • [7] Factors that make an infectious disease outbreak controllable
    Fraser, C
    Riley, S
    Anderson, RM
    Ferguson, NM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (16) : 6146 - 6151
  • [8] Gani R, 2005, EMERG INFECT DIS, V11, P1355
  • [9] Emerging infections: Pandemic influenza
    Glezen, WP
    [J]. EPIDEMIOLOGIC REVIEWS, 1996, 18 (01) : 64 - 76
  • [10] Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza - Randomized controlled trials for prevention and treatment
    Hayden, FG
    Treanor, JJ
    Fritz, RS
    Lobo, M
    Betts, RF
    Miller, M
    Kinnersley, N
    Mills, RG
    Ward, P
    Straus, SE
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (13): : 1240 - 1246